Cancer Center Seed Grant Awardees and New Review Committee Process
The MCW Cancer Center has instituted new seed grant processes, new scoring systems, and two new standing review committees. These new processes were used to review the current round of applications submitted, including the Kathy Duffey Fogarty Award for Breast Cancer Research, the Kurtis R. Froedtert Clinical Trials Seed Grant.
We are pleased to announce the following Cancer Center seed grant awards.
· Two awards of $50,000 for the Kathy Duffey Fogarty Award for Breast Cancer Research were given to Matthew Riese, MD, PhD, Assistant Professor, Department of Medicine at MCW for his project titled “Role of PECAM in mediating inhibitory effects of TGFβ on effector T cells” and to Mark McNally, PhD, Associate Professor, Department of Microbiology and Molecular Genetics at MCW for his project titled “Development of Antisense Oligonucleotides to Modulate SmgGDS in Breast Cancer.”
· The Kurtis R. Froedtert Clinical Trials Seed Grant was awarded to Ben George, MD, Assistant Professor, Department of Medicine at MCW for his project titled “A phase I/II Study of Intraperitoneal Docetaxel plus mFOLFOX6 for Gastric Cancer Patients with Peritoneal Carcinomatosis.”
Our two new committees reviewed the applications for these awards, and will review all future Cancer Center seed grants. The Basic Science Seed Grant Review Committee is chaired by Dr. Ravi Misra, and the 2) Clinical Research Seed Grant Review Committee is chaired by Dr. Bruce Campbell.
Dr. Misra and Dr. Campbell were chosen to lead these committees due to their visibility and reputation with Cancer Center leadership and membership, their knowledge of the NIH and seed grant processes, and their familiarity of basic and clinical cancer research occurring throughout the institution. Dr. Campbell and Dr. Misra have a long history of service to the Cancer Center, both formally and informally, and have a good handle on the needs and goals of MCW, the Cancer Center, and other cancer researchers.
Rotating review committee members consist of Cancer Center leadership, investigators who serve on NCI review sections, past and future seed grant awardees, and ad hoc members selected for their scientific expertise. Former seed grant awardees will be asked to serve on review committees in the spirit of “paying it forward” to support fellow cancer researchers and the Cancer Center.
This new process was designed to increase the potential and return on Cancer Center seed grants, and ensure that awards are distributed in a way that supports team science, translational science, and helps members become NCI-funded researchers. It also ensures that seed grant awards are closely aligned with the Cancer Center strategic plan and goals.
In addition to the new processes and committees, seed grant applications are evaluated using the NIH scoring system. This scoring system helps investigators use awards to generate important supporting evidence for future NIH grant applications, and helps the Cancer Center elevate the value of these awards in the eyes of our NCI reviewers, and the academic community in general.
These recent awards are part of the Cancer Center’s efforts to streamline the request for proposal process, and group RFPs together in twice-yearly announcements. The next RFA will be sent later this year. If you have any questions, or are interested in serving on one of the review committees, please contact Mike Anello, Research Grants Coordinator, at 955-2802 (email@example.com).